Stage III Cutaneous Melanoma AJCC v7 Active Not Recruiting Phase 1 Trials for Romidepsin (DB06176)

IndicationStatusPhase
DBCOND0091046 (Stage III Cutaneous Melanoma AJCC v7)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01638533
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionTreatment